Cadila Healthcare Limited has informed the Exchange regarding a press release dated December 09, 2020, titled "Zydus granted Fast Track Designation by the USFDA for Saroglitazar in the treatment of patients with Primary Biliary Cholangitis (PBC)".
Press Release Dec 09 2020
Filed with NSE ·
6ix hasn’t read this filing yet.
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release Dec 07 2020
- Press Release Dec 04 2020
- Press Release Nov 28 2020
- Press Release Nov 12 2020
- Press Release Nov 03 2020
Later from Zydus Lifesciences
- Press Release Dec 24 2020
- Press Release Dec 30 2020
- Press Release Jan 04 2021
- Press Release Jan 23 2021
- Press Release Jan 25 2021
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences